Jacques Hugon

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 194 publications

Eligibility for lecanemab treatment in a French memory clinic setting.

Eligibility for lecanemab treatment in a French memory clinic setting.

Journal: Journal of neurology

Published: January 09, 2026

Assessment of medication-related risks for mortality prediction in Alzheimer's disease.

Assessment of medication-related risks for mortality prediction in Alzheimer's disease.

Journal: Maturitas

Published: December 04, 2025

Association of Alzheimer's disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic study.

Association of Alzheimer's disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic study.

Journal: Alzheimer's research & therapy

Published: October 29, 2025

Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies.

Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies.

Journal: Journal of Alzheimer's disease : JAD

Published: October 22, 2025

Dual risk of anticholinergic burden and CSF alzheimer's biomarkers in older patients: a mortality follow-up study from daily medical practice.

Dual risk of anticholinergic burden and CSF alzheimer's biomarkers in older patients: a mortality follow-up study from daily medical practice.

Journal: Alzheimer's research & therapy

Published: May 15, 2025

Tau seeding activity in the cerebrospinal fluid of Alzheimer disease patients predicts short-term cognitive decline.

Tau seeding activity in the cerebrospinal fluid of Alzheimer disease patients predicts short-term cognitive decline.

Journal: Alzheimer's research & therapy

Published: April 14, 2025

Benefits of physical activity on cognitive function in patients with neurocognitive disorders: A systematic review.

Benefits of physical activity on cognitive function in patients with neurocognitive disorders: A systematic review.

Journal: The Journal of frailty & aging

Published: April 07, 2025

Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid.

Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid.

Journal: Clinical chemistry and laboratory medicine

Published: March 13, 2025

Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective study.

Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective study.

Journal: The journal of prevention of Alzheimer's disease

Published: January 12, 2025

Unraveling Homocysteine's Role in Dementia: No Specific Association with Alzheimer's Disease, but a Connection to White Matter Hyperintensities.

Unraveling Homocysteine's Role in Dementia: No Specific Association with Alzheimer's Disease, but a Connection to White Matter Hyperintensities.

Journal: Aging and disease

Published: January 06, 2025

Brain health: Pathway to primary prevention of neurodegenerative disorders of environmental origin.

Brain health: Pathway to primary prevention of neurodegenerative disorders of environmental origin.

Journal: Journal of the neurological sciences

Published: December 02, 2024

Non-canonical STAT3 pathway induces alterations of mitochondrial dynamic proteins in the hippocampus of an LPS-induced murine neuroinflammation model.

Non-canonical STAT3 pathway induces alterations of mitochondrial dynamic proteins in the hippocampus of an LPS-induced murine neuroinflammation model.

Journal: Neurochemistry international

Published: November 22, 2024

Showing 1-12 of 194

Last Updated: 09/26/2026